TY  - JOUR

T1  - Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (The FREEDOM-C2 Study): A randomized controlled trial

JO  - Chest

PY  - 2013/09/01

AU  - Tapson VF

AU  - Jing ZC

AU  - Xu KF

AU  - Pan L

AU  - Feldman J

AU  - Kiely DG

AU  - Kotlyar E

AU  - McSwain CS

AU  - Laliberte K

AU  - Arneson C

AU  - Rubin LJ

ED  - 

DO  - DOI: 10.1378/chest.12-2875

VL  - 144

IS  - 3

SP  - 952

EP  - 958

Y2  - 2025/01/13

ER  -